Pivotal Study to Evaluate Safety and Immunogenicity of a Live-Attenuated Chikungunya Virus Vaccine Candidate in Adults
Condition: Chikungunya Virus Infection Interventions: Biological: VLA1553; Biological: Placebo Sponsor: Valneva Austria GmbH Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials